Valvuloplasty is now widely accepted as the best method of treatment of mitral valve regurgitation, but repair for rheumatic mitral valve disease is commonly believed to yield poorer results by ...

The transcatheter heart valve replacement (TAVR) market is reported to reach a valuation of at USD 8.18 billion in 2025 to USD 32.82 billion by 2035. Demand for TAVR is expected to rise at a CAGR of ...